Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Simsek E. T., Eskazan A. E., Cengiz M., Ar M. C., Ekizoglu S., Salihoglu A., ...More

57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 126
  • City: Florida
  • Country: United States Of America
  • Istanbul University Affiliated: Yes